CompletedPhase 3NCT03725384

Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sunnybrook Health Sciences Centre
Principal Investigator
Dr.Yulia Lin
Sunnybrook Health Sciences Center
Intervention
Ferrous Sulfate 300Mg Tablet(drug)
Enrollment
51 enrolled
Eligibility
16 years · All sexes
Timeline
20192022

Study locations (2)

Collaborators

Unity Health Toronto

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03725384 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials